Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
ERISTA 2018 icon

8.1.0.0 by Launch Interactions


Nov 20, 2018

About ERISTA 2018

This is the official mobile app for ERISTA 2018.

Funding innovative medical research by European investigators since 2014

The BMS/Pfizer European Thrombosis Investigator-Initiated Research Program (ERISTA) was established to fund innovative medical research by European investigators.

This mobile app allows you to:

View schedules, explore sessions and find networking events.

Curate your own personal schedule for easy conference attendance.

Access location and speaker information at your fingertips.

Post updates to sessions & keynotes.

Interact with a real-time feed of all event activity, that showcases which sessions are trending, most popular photos, and popular discussion topics.

Expand your professional network

Features of the App:

Activity Feed - the real-time pulse of the event. See what people are saying, view photos from the event, and find trending sessions and topics.

Agenda - view the full agenda and related information (session time, room number, speaker info, etc)

Users - see who’s at the event, and connect with them on the app

What's New in the Latest Version 8.1.0.0

Last updated on Nov 20, 2018

Bug Fixes and Feature Enhancements

Translation Loading...

Additional APP Information

Latest Version

Request ERISTA 2018 Update 8.1.0.0

Uploaded by

Lạc Lý

Requires Android

Android 5.0+

Show More

ERISTA 2018 Screenshots

Comment Loading...
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.